Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.11 – $0.53
37% from low
Exchange
OTC Link
OS
PERIMETER MED IMAGING AI
No one on the platform currently holds PYNKF.
No tracked institution reports a position in PYNKF as of their last filing.
No one on the platform has traded PYNKF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $6M | +140.6% | $-0.06 | $-0.07–$-0.05 | — | 1 |
| 2027 | $14M | +131.7% | $-0.06 | $-0.06–$-0.04 | — | 1 |
| 2028 | $26M | +86.2% | $0.02 | $0.02–$0.02 | 13.2× | 1 |
| 2029 | $41M | +58.1% | $0.07 | $0.05–$0.08 | 3.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-28 | $-0.03 | $-0.02 | +20.0% |
| 2026-03-31 | $-0.03 | $-0.02 | +23.1% |
| 2025-11-12 | $-0.04 | $-0.04 | +0.0% |
| 2025-08-26 | $-0.07 | $-0.05 | +20.0% |
| 2025-05-13 | $-0.09 | $-0.07 | +16.7% |
| 2025-03-26 | $-0.07 | $-0.06 | +20.0% |
| 2024-11-14 | $-0.08 | $-0.07 | +11.5% |
| 2024-08-14 | $-0.08 |
| $-0.07 |
| +12.5% |
| $33M |
| — |
| GTHPGuided Therapeutics, Inc. | $0.24 | -17.24% | $23M | — |
| IPDQFImpediMed Limited | $0.00 | +36.36% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
$ELTP This stock was my first big winner and will always hold a special place in my heart 🥲 Come check out $PYNKF if you want another potential OTC runner. This company is still under the radar. They recently received FDA approval for their breast cancer identification device Claire and the entire trade thesis was hinging on commercialization. Yesterday they released news it’s being adopted in hospitals. 
View on StockTwits ↗$PYNKF has announced that Intermountain Health, in the Mountain West region, has become the first health system in the U.S. to commercially deploy Perimeter’s Claire OCT System, the only FDA-approved imaging device that uses AI during breast cancer surgery to help surgeons see microscopic tissue structures—where cancer can be difficult to detect—in real time, for margin assessment.
View on StockTwits ↗$PYNKF so are hospitals using their AI enabled machines now?
View on StockTwits ↗$PYNKF Brookline Capital Markets initiated coverage of Perimeter Medical Imaging with a “buy” rating and price target of C$1.54 (US$1.11). The stock closed at C$0.32 on July 13. https://biotuesdays.com/2026/07/14/brookline-starts-perimeter-at-buy-pt-c1-54/
View on StockTwits ↗Paradigm Capital names Perimeter Medical Imaging AI $PYNKF and maintains Profound Medical $PROF as healthcare Top Picks https://biotuesdays.com/2026/07/06/paradigm-capital-names-perimeter-and-maintains-profound-as-healthcare-top-picks/
View on StockTwits ↗$PYNKF has announced it has been selected to receive a contribution from the INOVAIT Pilot Fund to advance next-generation AI capabilities for its flagship product Claire, which received FDA approval earlier this year as the first AI-enabled device for use during breast cancer surgery. The project was one of 10 selected for funding in the latest round of the INOVAIT Pilot Fund call for applications. https://biotuesdays.com/2026/06/09/inovate-selects-perimeter-for-contribution-to-advance-ai-for-breast-cancer-surgery/
View on StockTwits ↗$PYNKF https://open.substack.com/pub/microcapopportunities/p/perimeter-medical-imaging-mco-thesis?r=flrqv&utm_campaign=post-expanded-share&utm_medium=web
View on StockTwits ↗$PYNKF wont be long before this company breaks out
View on StockTwits ↗$PYNKF’s FDA-approved Claire OCT+AI was recently highlighted during Chamath Palihapitiya’s appearance on The Joe Rogan Experience as part of a broader discussion on AI’s growing impact in healthcare. https://biotuesdays.com/2026/05/06/perimeters-fda-pma-approved-claire-octai-highlighted-on-the-joe-rogan-experience-podcast/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.